Home › Calculator › OGN Dividend Calculator 2026
OGN DRIP Calculator & Dividend Yield 2026
0.58% YieldHealthcareOrganon & Co. · NYSE
Price: $13.75 · Annual div: $0.0800/share · Frequency: quarterly · Payout ratio: 11% · Ex-div: 2026-08-14
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When OGN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
OGN Dividend History — Last 21 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-08-14Latest | 2026-09-10 | $0.0200 | 0.74% | $13.56 |
| 2026-05-11 | 2026-06-11 | $0.0200 | 0.75% | $13.29 |
| 2026-02-23 | 2026-03-12 | $0.0200 | 4.39% | $8.20 |
| 2025-11-20 | 2025-12-11 | $0.0200 | 5.07% | $6.71 |
| 2025-08-15 | 2025-09-11 | $0.0200 | 9.03% | $9.75 |
| 2025-05-12 | 2025-06-12 | $0.0200 | 9.10% | $9.45 |
| 2025-02-24 | 2025-03-13 | $0.2800 | 7.51% | $14.91 |
| 2024-11-12 | 2024-12-12 | $0.2800 | 6.20% | $18.07 |
| 2024-08-16 | 2024-09-12 | $0.2800 | 5.17% | $21.65 |
| 2024-05-10 | 2024-06-13 | $0.2800 | 7.43% | $18.83 |
| 2024-02-23 | 2024-03-14 | $0.2800 | 8.12% | $17.24 |
| 2023-11-10 | 2023-12-14 | $0.2800 | 7.65% | $14.65 |
| 2023-08-17 | 2023-09-14 | $0.2800 | 5.15% | $21.73 |
| 2023-05-12 | 2023-06-15 | $0.2800 | 5.71% | $24.50 |
| 2023-02-24 | 2023-03-16 | $0.2800 | 4.62% | $30.31 |
| 2022-11-10 | 2022-12-15 | $0.2800 | 5.31% | $26.39 |
| 2022-08-12 | 2022-09-15 | $0.2800 | 4.40% | $31.83 |
| 2022-05-13 | 2022-06-16 | $0.2800 | 3.49% | $32.08 |
| 2022-02-25 | 2022-03-17 | $0.2800 | 2.55% | $32.99 |
| 2021-11-19 | 2021-12-16 | $0.2800 | 1.51% | $37.13 |
| 2021-08-20 | 2021-09-13 | $0.2800 | 0.95% | $29.53 |
About Organon & Co. (OGN) — Dividend Analysis 2026
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.
Similar dividend stocks to OGN
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full OGN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OGN position with:
🌍 OGN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OGN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.58% | -2.22% | $58 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.49% | -2.31% | $49 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.46% | -2.34% | $46 / yr |
| 🇬🇧 UK ISA | 0% | 0.58% | -2.22% | $58 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.53% | -2.27% | $53 / yr |
| 🇨🇦 TFSA | 0% | 0.58% | -2.22% | $58 / yr |
| 🇨🇦 CA Taxable | 25% | 0.43% | -2.36% | $44 / yr |
| 🇦🇺 Super (pension) | 15% | 0.49% | -2.31% | $49 / yr |
| 🇦🇺 AU Taxable | 30% | 0.41% | -2.39% | $41 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.43% | -2.37% | $43 / yr |
| 🇫🇷 FR Taxable | 30% | 0.41% | -2.39% | $41 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 OGN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.08/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 OGN Dividend Payment Schedule
OGN pays quarterly — 4 times per year. Ex-div: 2026-08-14.
📊 OGN vs Healthcare Benchmarks
How OGN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OGN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ OGN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-08-11 | 11,519 | — | — | ||
| F-InKind | 2026-08-11 | 4,134 | $13.62 | $56.3K | ||
| M-Exempt | 2026-08-11 | 11,519 | — | — | ||
| Sale | 2026-08-05 | 14,761 | $13.57 | $200.3K | ||
| A-Award | 2026-06-12 | 17,857.143 | — | — | ||
| A-Award | 2026-06-12 | 17,857.143 | — | — | ||
| A-Award | 2026-06-12 | 17,857.143 | — | — | ||
| A-Award | 2026-06-12 | 17,857.143 | — | — | ||
| A-Award | 2026-06-12 | 17,857.143 | — | — | ||
| A-Award | 2026-06-12 | 17,857.143 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare OGN with peers: OGN vs ALVO · OGN vs AUPH · OGN vs AVDL
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where OGN earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OGN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Organon & Co. (OGN) is currently trading at $13.75, trading near its 52-week high. The current dividend yield is 0.58% based on an annual payout of $0.0800 per share.
OGN (Organon & Co.) — 0.58% Dividend Yield Analysis
Organon & Co. (OGN) is a healthcare stock currently trading at $13.75 with a dividend yield of 0.58%. It pays an annual dividend of $0.0800 per share. The payout ratio of 11% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest OGN News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the OGN dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.